Peter S Dragovich

15PUBLICATIONS
22CO-AUTHORS
Molecular targetsCharacterisation of biological macromoleculesPharmaceutical delivery technologiesGene and molecular therapyGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 18, 2026
Antibody-Mediated Delivery of BRM/BRG1 Protein Degraders Affords Strong Antitumor Efficacy in Multiple BRM-Dependent Non-Small Cell Lung Cancer Xenograft Models.

|Aug 08, 2025
Property-Based Prediction Uncovers Intestinal Excretion as an Elimination Route of Small-Molecule Drugs.

Chen Chen, Weiping Zhao, Lin Cao

|Jul 25, 2025
Elucidating Molecular Mechanisms of Drug-Induced Hepatotoxicity of Lapatinib.

Qinying Yu, Li Ma, Leah M Norona

|May 21, 2025
Correction to "PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models".

Michael Berlin, Jennifer Cantley, Mark Bookbinder

|Jan 05, 2024
PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models.

Michael Berlin, Jennifer Cantley, Mark Bookbinder

|May 04, 2022
Degrader-antibody conjugates.

Peter S Dragovich

Pageof 3

Frequent Collaborators

3 joint publications

Christopher M Rose

3 joint publications

Huifen Chen

2 joint publications

Donglu Zhang

2 joint publications

Stefan G Koenig